Optimized protocol for the radioiodination of hydrazone-type polymer drug delivery systems
Creators
Description
Hydrazone conjugates of polymers with doxorubicin represent a very promising tool for cancer chemotherapy. However, these conjugates are very difficult to radiolabel with iodine radionuclides, which possess otherwise very advantageous nuclear properties to, e.g., follow biodistribution. In this study, we developed a robust protocol for the high-yield radioiodination of hydrazone-type drug delivery systems with doxorubicin. In particular, it is crucial that the polymer radioiodination step be performed before the deprotection of the hydrazide and doxorubicin binding. - Highlights: • Hydrazone-type drug delivery systems with doxorubicin were radioiodinated. • Radioiodination was performed via polymer-bound phenolic moiety. • Radioiodination step must be performed before deprotection and drug binding
Availability note (English)
Available from http://dx.doi.org/10.1016/j.apradiso.2014.10.016Additional details
Identifiers
- DOI
- 10.1016/j.apradiso.2014.10.016;
- PII
- S0969-8043(14)00371-6;
Publishing Information
- Journal Title
- Applied Radiation and Isotopes
- Journal Volume
- 95
- Journal Issue
- Complete
- Journal Page Range
- p. 129-134
- ISSN
- 0969-8043
- CODEN
- ARISEF
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46103147
- Subject category
- S07: ISOTOPES AND RADIATION SOURCES;
- Descriptors DEI
- CHEMOTHERAPY; DELIVERY; DOXORUBICIN; HYDRAZONES; IODINE ISOTOPES; LABELLING; NEOPLASMS; PHENOLS; POLYMERS; RADIOISOTOPES; YIELDS
- Descriptors DEC
- ANTIBIOTICS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC DRUGS; AROMATICS; DISEASES; DRUGS; HYDROXY COMPOUNDS; ISOTOPES; MEDICINE; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; THERAPY
Optional Information
- Copyright
- Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.